A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/195 (2006.01) A61K 31/40 (2006.01) A61K 31/42 (2006.01) A61K 31/431 (2006.01) A61K 31/445 (2006.01) A61K 31/513 (2006.01) A61K 31/52 (2006.01) A61K 31/5375 (2006.01) A61K 31/58 (2006.01) A61K 31/6615 (2006.01) A61K 31/675 (2006.01) A61K 31/685 (2006.01) A61K 31/7008 (2006.01) A61K 31/7012 (2006.01) A61P 43/00 (2006.01)
Patent
CA 2691937
The present invention provides a compound which is an inhibitor of sphingolipid biosynthesis for use in the treatment of a disease which has a secondary Niemann-Pick type C disease like cellular phenotype.
La présente invention concerne un composé qui est un inhibiteur de la biosynthèse de sphingolipides, à utiliser pour le traitement d'une maladie présentant une phénotype cellulaire secondaire de type maladie de Niemann-Pick de type C.
Lloyd-Evans Emyr
Platt Frances Mary
Porter Forbes Dennison
Departmen T. Of Health And Human Services The United States Of America As Represented By The Secretary
Smart & Biggar
The Chancellor Masters And Scholars Of The University Of Oxford
LandOfFree
Substrate reduction therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substrate reduction therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substrate reduction therapy will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1870778